Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation
Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders
Biotechnology | 08/06/2020 | By Darshana | 728
FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Today the U.S. Food and Drug Administration took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website
Biotechnology | 01/06/2020 | By Darshana | 176
Today the U.S. Food and Drug Administration took a new step to support the agency's evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are an additional step to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance
Biotechnology | 28/05/2020 | By Darshana | 183
ICMR to present fully indigenous diagnostic platform for COVID-19
The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.
Biotechnology | 25/05/2020 | By Darshana | 297
FDA Provides Promised Transparency for Antibody Tests
Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the notification list of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency
Biotechnology | 22/05/2020 | By Darshana | 193
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment
Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT
Biotechnology | 15/05/2020 | By Darshana | 344
ICMR notifies NIMHANS as mentor institution for RT-PCR test protocol for COVID-19
The National Institute of Mental Health and Neuro Sciences (NIMHANS) has been notified by the Indian Council of Medical Research (ICMR) and the Medical Council of India (MCI) as the mentor institution for RT-PCR (Reverse transcription-polymerase chain reaction) test
Biotechnology | 10/05/2020 | By Darshana | 371
Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research
Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe
Biotechnology | 29/04/2020 | By Darshana | 194
Alembic Pharma gets US FDA approval for Lastacaft ophthalmic solution
Alembic Pharmaceuticals Limited has received tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) alcaftadine ophthalmic solution, 0.25%
Biotechnology | 21/04/2020 | By Darshana | 768
Oncolytics Biotech updates clinical development & operations activities during COVID-19 pandemic
Oncolytics Biotech Inc., currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, provided an update on the potential impact of COVID-19 on the company's clinical and business operations
Biotechnology | 20/04/2020 | By Darshana | 314
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy